Advertisement
Advertisement

TVTX

TVTX logo

Travere Therapeutics, Inc. Common Stock

65.67
USD
Sponsored
-1.85
-2.74%
Aug 28, 15:59 UTC -4
Closed
exchange

Pre-Market

65.80

+0.13
+0.20%

Travere Therapeutics, Inc. Common Stock Profile

About

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

Info & Links

CEO

Eric Dube

Headquarters

3611 VALLEY CENTRE DR, SUITE 300
SAN DIEGO, CA 92130, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.travere.com

Auditor

Ernst & Young LLP

Share holders

158

Employees

497

Travere Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.20B

Enterprise Value

6.69B

Enterprise Value/EBITDA(ttm)

332.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

10.47

Price to Book(mrq)

252.43

Price to Cash(ytd)

181.34

Profitability

Gross Margin(ttm)

98.56%

Operating Margin(ttm)

-7.27%

Profit Margin(ttm)

-8.00%

Return on Equity(ttm)

-55.15%

Return on Invested Capital(ttm)

-12.93%

Return on Assets(ttm)

-6.88%

Income Statement

Revenue(ttm)

591.33M

Revenue Per Share(ttm)

6.27

Gross Profit(ttm)

583.07M

EBITDA(ttm)3

20.11M

Net Income Available to Common(ttm)

-43.46M

Diluted EPS(ttm)

-0.46

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

275.26%

S&P 500 52-Week Change

19.58%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

94.26M

Dividend Yield

0.00%

Float4

90.08M

% Held by Insiders

4.44%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

489.18M

Total Cash Per Share(mrq)

5.19

Total Debt(mrq)

602.78M

Total Debt/Equity(mrq)

2458.12%

Current Ratio(mrq)

4.05%

Quick Ratio(mrq)

3.99%

Book Value Per Share(mrq)

0.26

Cash Flow

Operating Cash Flow Per Share(ytd)

0.19

Free Cash Flow(ytd)

17.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement